Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments
Topics: Autoimmune, Multiple Sclerosis (MS), Research & Development
|
Systemic Lupus Erythematosus – Pipeline Review, H1 2012
Topics: Autoimmune, Drug Discovery
|
Psoriasis – Pipeline Review, H1 2012
Topics: Autoimmune, Drug Discovery
|
Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success
Topics: Autoimmune, Clinical Trial
|
Liver Disease Treatments: The Global Market
Topics: Hepatitis, Autoimmune, Vaccines
Regions: Global
|
Celiac Disease - Pipeline Assessment and Market Forecasts to 2019
Topics: Autoimmune, Drug Discovery
|
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market
Topics: Antibody Technologies, Autoimmune
|
Auto Inflammatory Disease - Pipeline Review, H2 2011
Topics: Autoimmune, Drug Discovery
|
Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2011
Topics: Autoimmune, Drug Discovery
|
Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market
Topics: Autoimmune, Research & Development
|
Neuromodulation Devices: World Market Prospects 2011-2021
Topics: Autoimmune, Medical Devices, Orthopedics
|
Drugs and Treatments for Autoimmune Diseases: Global Markets
Topics: Autoimmune
Regions: Global
|
Celiac Disease - Pipeline Review, H2 2011
Topics: Autoimmune, Drug Discovery
|
Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth
Topics: Autoimmune, Research & Development, Drug Discovery
|
Autoimmune Market Access in China - New biologic therapies drive future growth
Topics: Autoimmune
Regions: China
|
Autoimmune Market Access in China – New biologic therapies drive future growth
Topics: Autoimmune, Manufacturing, Packaging & Detailing, Drug Discovery
Regions: China
|
Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade
Topics: Autoimmune, Clinical Trial
|
Report: Do the Emerging Treatments for Celiac Disease Offer Significant Improvements over the Gluten-Free Diet?
Topics: Genomics, Autoimmune, Drug Discovery
|
Strategic Overview of the Autoimmune Biologics Market
Topics: Autoimmune, Research & Development
|
Chronic Plaque Psoriasis - Pipeline Review, H2 2011
Topics: Autoimmune, Drug Discovery
|
Special Report: The Autoimmune Biologics Pipeline—A Competitive Review
Topics: Autoimmune, Research & Development
|
Special Report: The Pricing and Reimbursement Environment for Autoimmune Biologics
Topics: Autoimmune, Pricing
|
ProtAb Private Vendor Watchlist Profile: Therapeutic Antibodies for Treating Autoimmune Diseases
Topics: Antibody Technologies, Autoimmune
|
Product Profiles: Systemic Lupus Erythematosus - Benlysta approval brings lessons and hope to market
Topics: Autoimmune, Drug Discovery, Clinical Trial
|
Chronic Plaque Psoriasis Global Clinical Trials Review, Q2, 2011
Topics: Autoimmune, Drug Discovery
|
Systemic Lupus Erythematosus Global Clinical Trials Review, Q2, 2011
Topics: Autoimmune, Drug Discovery
|
Celiac Disease Global Clinical Trials Review, Q2, 2011
Topics: Autoimmune, Drug Discovery
|
Use of Biomarkers to Predict Response to Biologics Therapy in Autoimmune Diseases
Topics: Biomarkers, Autoimmune
|
Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, Q2 2011
Topics: Autoimmune, Drug Discovery
|
R&D Trends: Systemic Lupus Erythematosus - Benlysta's FDA approval provides hope for disease treatment, future trial design, and other pipeline candidates
Topics: Autoimmune, Drug Discovery
|
Psoriasis Market Info™
Topics: Autoimmune, Research & Development, Drug Discovery
Regions: United States
|
Guillain Barre Syndrome (GBS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Topics: Autoimmune, Drug Discovery
|
Chronic Plaque Psoriasis - Pipeline Review, Q2 2011
Topics: Autoimmune, Research & Development
|
Psoriasis Global Clinical Trials Review, Q1, 2011
Topics: Autoimmune, Drug Discovery, Clinical Trial
|
Epidemiology: Psoriasis
Topics: Autoimmune, Drug Discovery
|
European Market for Nutritional Solutions in Immune and Antihypertensive Health
Topics: Hypertension, Autoimmune, Ingredients
Regions: Europe
|
Epidemiology: Lupus
Topics: Autoimmune, Drug Discovery
|
R&D Trends: Psoriasis - Pipeline outlook following withdrawal of key regulatory filing
Topics: Autoimmune, Research & Development, Drug Discovery
|
Autoimmune Diseases Therapy Area Pipeline Report
Topics: Autoimmune
|
Psoriasis Therapy Area Pipeline Report
Topics: Autoimmune
|
Systemic Lupus Erythematosus Therapy Area Pipeline Report
Topics: Autoimmune, Drug Discovery
|
Lupus Nephritis Therapeutics - Pipeline Assessment and Market Forecast to 2017
Topics: Autoimmune, Drug Discovery
|
Systemic Lupus Erythematosus - Pipeline Review, Q1 2011
Topics: Autoimmune, Drug Discovery
|
Celiac Disease - Pipeline Review, Q1 2011
Topics: Autoimmune, Drug Discovery
|
Therapeutics for Immune System Disorders
Topics: Autoimmune, General In Vitro Diagnostics, Drug Discovery
|
Autoimmune Diseases Therapy Pipeline Report
Topics: Autoimmune, Drug Discovery
|
Systemic Lupus Erythematosus Therapy Pipeline Report
Topics: Autoimmune, Drug Discovery
|
Chronic Plaque Psoriasis - Pipeline Review, Q4 2010
Topics: Autoimmune, Drug Discovery
|
Disease and Therapy Review: Crohn's Disease
Topics: Autoimmune, Crohn's, Gastrointestinal
|
Psoriasis Market Forecast
Topics: Autoimmune, Drug Discovery
|
